Jamie M.

Jamie (James) M. has a diverse work experience in finance and accounting. Jamie (James) currently holds the position of VP of Finance & Controller at Sigilon Therapeutics, Inc. Jamie (James) joined the company in January 2022 and has been responsible for financial management and control. Prior to this role, they served as Sr. Director, Controller from July 2021 to December 2021 and as Controller from November 2020 to June 2021.

Before joining Sigilon Therapeutics, Jamie worked at Larimar Therapeutics (formerly Zafgen, Inc.) starting in May 2018. During their time there, they held multiple roles, including Finance & Accounting Consultant and Corporate Controller. In these positions, they managed various accounting functions, prepared and filed SEC filings, and presented quarterly results to the Audit Committee. Jamie (James) also developed and implemented a SOX404(b) compliant control environment.

Jamie's earlier work experience includes working at PwC as an Assurance Manager. Jamie (James) was responsible for managing audit engagements for clients in the life sciences, bio-pharmaceutical, healthcare provider, and technology industries. Jamie (James) also had extensive experience in auditing, researching technical accounting issues, and collaborating with partners on engagement budgets and staffing.

Overall, Jamie has a strong background in finance and accounting, with expertise in financial management, SEC filings, internal controls, and audit engagements.

Jamie (James) M. completed a Bachelor of Science degree in Business and History at Wake Forest University from 2006 to 2010. From 2010 to 2011, Jamie pursued a dual-degree program, earning a Master of Science in Accounting/Master of Business Administration (MSA/MBA) from the D'Amore-McKim School of Business at Northeastern University. Additionally, Jamie obtained certification as a Certified Public Accountant (CPA).